The Allstate Co. (NYSE:ALL) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of The Allstate Co. (NYSE:ALL - Free Report) by 24.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,358,883 shares of the insurance provider's stock after buying an additional 462,613 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.89% of Allstate worth $454,769,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of ALL. Wealthcare Advisory Partners LLC grew its holdings in shares of Allstate by 30.5% during the fourth quarter. Wealthcare Advisory Partners LLC now owns 1,456 shares of the insurance provider's stock valued at $281,000 after buying an additional 340 shares in the last quarter. Merit Financial Group LLC grew its holdings in shares of Allstate by 78.9% during the fourth quarter. Merit Financial Group LLC now owns 3,909 shares of the insurance provider's stock valued at $754,000 after buying an additional 1,724 shares in the last quarter. Ameritas Advisory Services LLC grew its holdings in shares of Allstate by 117.3% during the fourth quarter. Ameritas Advisory Services LLC now owns 4,896 shares of the insurance provider's stock valued at $944,000 after buying an additional 2,643 shares in the last quarter. Aaron Wealth Advisors LLC grew its holdings in shares of Allstate by 9.5% during the fourth quarter. Aaron Wealth Advisors LLC now owns 1,660 shares of the insurance provider's stock valued at $320,000 after buying an additional 144 shares in the last quarter. Finally, Grove Bank & Trust boosted its position in Allstate by 88.8% during the fourth quarter. Grove Bank & Trust now owns 755 shares of the insurance provider's stock valued at $146,000 after purchasing an additional 355 shares during the last quarter. Hedge funds and other institutional investors own 76.47% of the company's stock.

Allstate Trading Down 0.9%

Allstate stock opened at $208.09 on Wednesday. The business has a 50 day moving average price of $199.83 and a two-hundred day moving average price of $196.02. The company has a quick ratio of 0.40, a current ratio of 0.36 and a debt-to-equity ratio of 0.42. The stock has a market cap of $55.11 billion, a price-to-earnings ratio of 12.25, a price-to-earnings-growth ratio of 1.01 and a beta of 0.32. The Allstate Co. has a 12 month low of $156.66 and a 12 month high of $212.91.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $3.53 EPS for the quarter, missing the consensus estimate of $3.98 by ($0.45). The firm had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. Allstate had a net margin of 7.28% and a return on equity of 28.20%. The company's revenue was up 7.8% on a year-over-year basis. During the same period last year, the company earned $5.13 EPS. As a group, equities analysts forecast that The Allstate Co. will post 18.74 EPS for the current year.

Allstate Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were issued a $1.00 dividend. This is a boost from Allstate's previous quarterly dividend of $0.92. The ex-dividend date of this dividend was Monday, March 10th. This represents a $4.00 annualized dividend and a yield of 1.92%. Allstate's dividend payout ratio is 27.32%.

Allstate declared that its board has approved a stock repurchase plan on Wednesday, February 26th that permits the company to repurchase $1.50 billion in shares. This repurchase authorization permits the insurance provider to buy up to 3% of its shares through open market purchases. Shares repurchase plans are often an indication that the company's leadership believes its stock is undervalued.

Wall Street Analysts Forecast Growth

ALL has been the subject of a number of research reports. Wells Fargo & Company reduced their price objective on Allstate from $200.00 to $197.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Argus raised Allstate from a "hold" rating to a "buy" rating in a research report on Monday, March 3rd. BMO Capital Markets reaffirmed an "outperform" rating on shares of Allstate in a research report on Friday. StockNews.com raised Allstate from a "hold" rating to a "buy" rating in a research report on Thursday, May 1st. Finally, Evercore ISI boosted their price target on Allstate from $227.00 to $230.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. One analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Allstate has an average rating of "Moderate Buy" and an average price target of $225.20.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.